Global CAR-T Drugs Supply, Demand and Key Producers, 2023-2029
The global CAR-T Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global CAR-T Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for CAR-T Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of CAR-T Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global CAR-T Drugs total production and demand, 2018-2029, (K Units)
Global CAR-T Drugs total production value, 2018-2029, (USD Million)
Global CAR-T Drugs production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global CAR-T Drugs consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: CAR-T Drugs domestic production, consumption, key domestic manufacturers and share
Global CAR-T Drugs production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global CAR-T Drugs production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global CAR-T Drugs production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global CAR-T Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Gilead Sciences, WuXi Biologics, Sanofi, Juno Therapeutics, Bluebird Bio, Cellectis, Precision Biosciences and CRISPR Therapeutics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World CAR-T Drugs market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global CAR-T Drugs Market, By Region:
1. How big is the global CAR-T Drugs market?
2. What is the demand of the global CAR-T Drugs market?
3. What is the year over year growth of the global CAR-T Drugs market?
4. What is the production and production value of the global CAR-T Drugs market?
5. Who are the key producers in the global CAR-T Drugs market?
This report studies the global CAR-T Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for CAR-T Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of CAR-T Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global CAR-T Drugs total production and demand, 2018-2029, (K Units)
Global CAR-T Drugs total production value, 2018-2029, (USD Million)
Global CAR-T Drugs production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global CAR-T Drugs consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: CAR-T Drugs domestic production, consumption, key domestic manufacturers and share
Global CAR-T Drugs production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global CAR-T Drugs production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global CAR-T Drugs production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global CAR-T Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Gilead Sciences, WuXi Biologics, Sanofi, Juno Therapeutics, Bluebird Bio, Cellectis, Precision Biosciences and CRISPR Therapeutics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World CAR-T Drugs market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global CAR-T Drugs Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- CD19 CAR-T
- BCMACAR-T
- Others
- Hematoma
- Solid Tumors
- Others
- Novartis
- Gilead Sciences
- WuXi Biologics
- Sanofi
- Juno Therapeutics
- Bluebird Bio
- Cellectis
- Precision Biosciences
- CRISPR Therapeutics
- Autolus Therapeutics
- Adaptimmune Therapeutics
- Atara Biotherapeutics
- Tmunity Therapeutics
- Iovance Biotherapeutics
- Celyad Oncology
1. How big is the global CAR-T Drugs market?
2. What is the demand of the global CAR-T Drugs market?
3. What is the year over year growth of the global CAR-T Drugs market?
4. What is the production and production value of the global CAR-T Drugs market?
5. Who are the key producers in the global CAR-T Drugs market?
1 SUPPLY SUMMARY
1.1 CAR-T Drugs Introduction
1.2 World CAR-T Drugs Supply & Forecast
1.2.1 World CAR-T Drugs Production Value (2018 & 2022 & 2029)
1.2.2 World CAR-T Drugs Production (2018-2029)
1.2.3 World CAR-T Drugs Pricing Trends (2018-2029)
1.3 World CAR-T Drugs Production by Region (Based on Production Site)
1.3.1 World CAR-T Drugs Production Value by Region (2018-2029)
1.3.2 World CAR-T Drugs Production by Region (2018-2029)
1.3.3 World CAR-T Drugs Average Price by Region (2018-2029)
1.3.4 North America CAR-T Drugs Production (2018-2029)
1.3.5 Europe CAR-T Drugs Production (2018-2029)
1.3.6 China CAR-T Drugs Production (2018-2029)
1.3.7 Japan CAR-T Drugs Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 CAR-T Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 CAR-T Drugs Major Market Trends
2 DEMAND SUMMARY
2.1 World CAR-T Drugs Demand (2018-2029)
2.2 World CAR-T Drugs Consumption by Region
2.2.1 World CAR-T Drugs Consumption by Region (2018-2023)
2.2.2 World CAR-T Drugs Consumption Forecast by Region (2024-2029)
2.3 United States CAR-T Drugs Consumption (2018-2029)
2.4 China CAR-T Drugs Consumption (2018-2029)
2.5 Europe CAR-T Drugs Consumption (2018-2029)
2.6 Japan CAR-T Drugs Consumption (2018-2029)
2.7 South Korea CAR-T Drugs Consumption (2018-2029)
2.8 ASEAN CAR-T Drugs Consumption (2018-2029)
2.9 India CAR-T Drugs Consumption (2018-2029)
3 WORLD CAR-T DRUGS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World CAR-T Drugs Production Value by Manufacturer (2018-2023)
3.2 World CAR-T Drugs Production by Manufacturer (2018-2023)
3.3 World CAR-T Drugs Average Price by Manufacturer (2018-2023)
3.4 CAR-T Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global CAR-T Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for CAR-T Drugs in 2022
3.5.3 Global Concentration Ratios (CR8) for CAR-T Drugs in 2022
3.6 CAR-T Drugs Market: Overall Company Footprint Analysis
3.6.1 CAR-T Drugs Market: Region Footprint
3.6.2 CAR-T Drugs Market: Company Product Type Footprint
3.6.3 CAR-T Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: CAR-T Drugs Production Value Comparison
4.1.1 United States VS China: CAR-T Drugs Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: CAR-T Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: CAR-T Drugs Production Comparison
4.2.1 United States VS China: CAR-T Drugs Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: CAR-T Drugs Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: CAR-T Drugs Consumption Comparison
4.3.1 United States VS China: CAR-T Drugs Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: CAR-T Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based CAR-T Drugs Manufacturers and Market Share, 2018-2023
4.4.1 United States Based CAR-T Drugs Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers CAR-T Drugs Production Value (2018-2023)
4.4.3 United States Based Manufacturers CAR-T Drugs Production (2018-2023)
4.5 China Based CAR-T Drugs Manufacturers and Market Share
4.5.1 China Based CAR-T Drugs Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers CAR-T Drugs Production Value (2018-2023)
4.5.3 China Based Manufacturers CAR-T Drugs Production (2018-2023)
4.6 Rest of World Based CAR-T Drugs Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based CAR-T Drugs Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers CAR-T Drugs Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers CAR-T Drugs Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World CAR-T Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 CD19 CAR-T
5.2.2 BCMACAR-T
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World CAR-T Drugs Production by Type (2018-2029)
5.3.2 World CAR-T Drugs Production Value by Type (2018-2029)
5.3.3 World CAR-T Drugs Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World CAR-T Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hematoma
6.2.2 Solid Tumors
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World CAR-T Drugs Production by Application (2018-2029)
6.3.2 World CAR-T Drugs Production Value by Application (2018-2029)
6.3.3 World CAR-T Drugs Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Novartis
7.1.1 Novartis Details
7.1.2 Novartis Major Business
7.1.3 Novartis CAR-T Drugs Product and Services
7.1.4 Novartis CAR-T Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Novartis Recent Developments/Updates
7.1.6 Novartis Competitive Strengths & Weaknesses
7.2 Gilead Sciences
7.2.1 Gilead Sciences Details
7.2.2 Gilead Sciences Major Business
7.2.3 Gilead Sciences CAR-T Drugs Product and Services
7.2.4 Gilead Sciences CAR-T Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Gilead Sciences Recent Developments/Updates
7.2.6 Gilead Sciences Competitive Strengths & Weaknesses
7.3 WuXi Biologics
7.3.1 WuXi Biologics Details
7.3.2 WuXi Biologics Major Business
7.3.3 WuXi Biologics CAR-T Drugs Product and Services
7.3.4 WuXi Biologics CAR-T Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 WuXi Biologics Recent Developments/Updates
7.3.6 WuXi Biologics Competitive Strengths & Weaknesses
7.4 Sanofi
7.4.1 Sanofi Details
7.4.2 Sanofi Major Business
7.4.3 Sanofi CAR-T Drugs Product and Services
7.4.4 Sanofi CAR-T Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Sanofi Recent Developments/Updates
7.4.6 Sanofi Competitive Strengths & Weaknesses
7.5 Juno Therapeutics
7.5.1 Juno Therapeutics Details
7.5.2 Juno Therapeutics Major Business
7.5.3 Juno Therapeutics CAR-T Drugs Product and Services
7.5.4 Juno Therapeutics CAR-T Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Juno Therapeutics Recent Developments/Updates
7.5.6 Juno Therapeutics Competitive Strengths & Weaknesses
7.6 Bluebird Bio
7.6.1 Bluebird Bio Details
7.6.2 Bluebird Bio Major Business
7.6.3 Bluebird Bio CAR-T Drugs Product and Services
7.6.4 Bluebird Bio CAR-T Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Bluebird Bio Recent Developments/Updates
7.6.6 Bluebird Bio Competitive Strengths & Weaknesses
7.7 Cellectis
7.7.1 Cellectis Details
7.7.2 Cellectis Major Business
7.7.3 Cellectis CAR-T Drugs Product and Services
7.7.4 Cellectis CAR-T Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Cellectis Recent Developments/Updates
7.7.6 Cellectis Competitive Strengths & Weaknesses
7.8 Precision Biosciences
7.8.1 Precision Biosciences Details
7.8.2 Precision Biosciences Major Business
7.8.3 Precision Biosciences CAR-T Drugs Product and Services
7.8.4 Precision Biosciences CAR-T Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Precision Biosciences Recent Developments/Updates
7.8.6 Precision Biosciences Competitive Strengths & Weaknesses
7.9 CRISPR Therapeutics
7.9.1 CRISPR Therapeutics Details
7.9.2 CRISPR Therapeutics Major Business
7.9.3 CRISPR Therapeutics CAR-T Drugs Product and Services
7.9.4 CRISPR Therapeutics CAR-T Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 CRISPR Therapeutics Recent Developments/Updates
7.9.6 CRISPR Therapeutics Competitive Strengths & Weaknesses
7.10 Autolus Therapeutics
7.10.1 Autolus Therapeutics Details
7.10.2 Autolus Therapeutics Major Business
7.10.3 Autolus Therapeutics CAR-T Drugs Product and Services
7.10.4 Autolus Therapeutics CAR-T Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Autolus Therapeutics Recent Developments/Updates
7.10.6 Autolus Therapeutics Competitive Strengths & Weaknesses
7.11 Adaptimmune Therapeutics
7.11.1 Adaptimmune Therapeutics Details
7.11.2 Adaptimmune Therapeutics Major Business
7.11.3 Adaptimmune Therapeutics CAR-T Drugs Product and Services
7.11.4 Adaptimmune Therapeutics CAR-T Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Adaptimmune Therapeutics Recent Developments/Updates
7.11.6 Adaptimmune Therapeutics Competitive Strengths & Weaknesses
7.12 Atara Biotherapeutics
7.12.1 Atara Biotherapeutics Details
7.12.2 Atara Biotherapeutics Major Business
7.12.3 Atara Biotherapeutics CAR-T Drugs Product and Services
7.12.4 Atara Biotherapeutics CAR-T Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Atara Biotherapeutics Recent Developments/Updates
7.12.6 Atara Biotherapeutics Competitive Strengths & Weaknesses
7.13 Tmunity Therapeutics
7.13.1 Tmunity Therapeutics Details
7.13.2 Tmunity Therapeutics Major Business
7.13.3 Tmunity Therapeutics CAR-T Drugs Product and Services
7.13.4 Tmunity Therapeutics CAR-T Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Tmunity Therapeutics Recent Developments/Updates
7.13.6 Tmunity Therapeutics Competitive Strengths & Weaknesses
7.14 Iovance Biotherapeutics
7.14.1 Iovance Biotherapeutics Details
7.14.2 Iovance Biotherapeutics Major Business
7.14.3 Iovance Biotherapeutics CAR-T Drugs Product and Services
7.14.4 Iovance Biotherapeutics CAR-T Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Iovance Biotherapeutics Recent Developments/Updates
7.14.6 Iovance Biotherapeutics Competitive Strengths & Weaknesses
7.15 Celyad Oncology
7.15.1 Celyad Oncology Details
7.15.2 Celyad Oncology Major Business
7.15.3 Celyad Oncology CAR-T Drugs Product and Services
7.15.4 Celyad Oncology CAR-T Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Celyad Oncology Recent Developments/Updates
7.15.6 Celyad Oncology Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 CAR-T Drugs Industry Chain
8.2 CAR-T Drugs Upstream Analysis
8.2.1 CAR-T Drugs Core Raw Materials
8.2.2 Main Manufacturers of CAR-T Drugs Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 CAR-T Drugs Production Mode
8.6 CAR-T Drugs Procurement Model
8.7 CAR-T Drugs Industry Sales Model and Sales Channels
8.7.1 CAR-T Drugs Sales Model
8.7.2 CAR-T Drugs Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 CAR-T Drugs Introduction
1.2 World CAR-T Drugs Supply & Forecast
1.2.1 World CAR-T Drugs Production Value (2018 & 2022 & 2029)
1.2.2 World CAR-T Drugs Production (2018-2029)
1.2.3 World CAR-T Drugs Pricing Trends (2018-2029)
1.3 World CAR-T Drugs Production by Region (Based on Production Site)
1.3.1 World CAR-T Drugs Production Value by Region (2018-2029)
1.3.2 World CAR-T Drugs Production by Region (2018-2029)
1.3.3 World CAR-T Drugs Average Price by Region (2018-2029)
1.3.4 North America CAR-T Drugs Production (2018-2029)
1.3.5 Europe CAR-T Drugs Production (2018-2029)
1.3.6 China CAR-T Drugs Production (2018-2029)
1.3.7 Japan CAR-T Drugs Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 CAR-T Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 CAR-T Drugs Major Market Trends
2 DEMAND SUMMARY
2.1 World CAR-T Drugs Demand (2018-2029)
2.2 World CAR-T Drugs Consumption by Region
2.2.1 World CAR-T Drugs Consumption by Region (2018-2023)
2.2.2 World CAR-T Drugs Consumption Forecast by Region (2024-2029)
2.3 United States CAR-T Drugs Consumption (2018-2029)
2.4 China CAR-T Drugs Consumption (2018-2029)
2.5 Europe CAR-T Drugs Consumption (2018-2029)
2.6 Japan CAR-T Drugs Consumption (2018-2029)
2.7 South Korea CAR-T Drugs Consumption (2018-2029)
2.8 ASEAN CAR-T Drugs Consumption (2018-2029)
2.9 India CAR-T Drugs Consumption (2018-2029)
3 WORLD CAR-T DRUGS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World CAR-T Drugs Production Value by Manufacturer (2018-2023)
3.2 World CAR-T Drugs Production by Manufacturer (2018-2023)
3.3 World CAR-T Drugs Average Price by Manufacturer (2018-2023)
3.4 CAR-T Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global CAR-T Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for CAR-T Drugs in 2022
3.5.3 Global Concentration Ratios (CR8) for CAR-T Drugs in 2022
3.6 CAR-T Drugs Market: Overall Company Footprint Analysis
3.6.1 CAR-T Drugs Market: Region Footprint
3.6.2 CAR-T Drugs Market: Company Product Type Footprint
3.6.3 CAR-T Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: CAR-T Drugs Production Value Comparison
4.1.1 United States VS China: CAR-T Drugs Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: CAR-T Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: CAR-T Drugs Production Comparison
4.2.1 United States VS China: CAR-T Drugs Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: CAR-T Drugs Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: CAR-T Drugs Consumption Comparison
4.3.1 United States VS China: CAR-T Drugs Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: CAR-T Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based CAR-T Drugs Manufacturers and Market Share, 2018-2023
4.4.1 United States Based CAR-T Drugs Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers CAR-T Drugs Production Value (2018-2023)
4.4.3 United States Based Manufacturers CAR-T Drugs Production (2018-2023)
4.5 China Based CAR-T Drugs Manufacturers and Market Share
4.5.1 China Based CAR-T Drugs Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers CAR-T Drugs Production Value (2018-2023)
4.5.3 China Based Manufacturers CAR-T Drugs Production (2018-2023)
4.6 Rest of World Based CAR-T Drugs Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based CAR-T Drugs Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers CAR-T Drugs Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers CAR-T Drugs Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World CAR-T Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 CD19 CAR-T
5.2.2 BCMACAR-T
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World CAR-T Drugs Production by Type (2018-2029)
5.3.2 World CAR-T Drugs Production Value by Type (2018-2029)
5.3.3 World CAR-T Drugs Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World CAR-T Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hematoma
6.2.2 Solid Tumors
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World CAR-T Drugs Production by Application (2018-2029)
6.3.2 World CAR-T Drugs Production Value by Application (2018-2029)
6.3.3 World CAR-T Drugs Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Novartis
7.1.1 Novartis Details
7.1.2 Novartis Major Business
7.1.3 Novartis CAR-T Drugs Product and Services
7.1.4 Novartis CAR-T Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Novartis Recent Developments/Updates
7.1.6 Novartis Competitive Strengths & Weaknesses
7.2 Gilead Sciences
7.2.1 Gilead Sciences Details
7.2.2 Gilead Sciences Major Business
7.2.3 Gilead Sciences CAR-T Drugs Product and Services
7.2.4 Gilead Sciences CAR-T Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Gilead Sciences Recent Developments/Updates
7.2.6 Gilead Sciences Competitive Strengths & Weaknesses
7.3 WuXi Biologics
7.3.1 WuXi Biologics Details
7.3.2 WuXi Biologics Major Business
7.3.3 WuXi Biologics CAR-T Drugs Product and Services
7.3.4 WuXi Biologics CAR-T Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 WuXi Biologics Recent Developments/Updates
7.3.6 WuXi Biologics Competitive Strengths & Weaknesses
7.4 Sanofi
7.4.1 Sanofi Details
7.4.2 Sanofi Major Business
7.4.3 Sanofi CAR-T Drugs Product and Services
7.4.4 Sanofi CAR-T Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Sanofi Recent Developments/Updates
7.4.6 Sanofi Competitive Strengths & Weaknesses
7.5 Juno Therapeutics
7.5.1 Juno Therapeutics Details
7.5.2 Juno Therapeutics Major Business
7.5.3 Juno Therapeutics CAR-T Drugs Product and Services
7.5.4 Juno Therapeutics CAR-T Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Juno Therapeutics Recent Developments/Updates
7.5.6 Juno Therapeutics Competitive Strengths & Weaknesses
7.6 Bluebird Bio
7.6.1 Bluebird Bio Details
7.6.2 Bluebird Bio Major Business
7.6.3 Bluebird Bio CAR-T Drugs Product and Services
7.6.4 Bluebird Bio CAR-T Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Bluebird Bio Recent Developments/Updates
7.6.6 Bluebird Bio Competitive Strengths & Weaknesses
7.7 Cellectis
7.7.1 Cellectis Details
7.7.2 Cellectis Major Business
7.7.3 Cellectis CAR-T Drugs Product and Services
7.7.4 Cellectis CAR-T Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Cellectis Recent Developments/Updates
7.7.6 Cellectis Competitive Strengths & Weaknesses
7.8 Precision Biosciences
7.8.1 Precision Biosciences Details
7.8.2 Precision Biosciences Major Business
7.8.3 Precision Biosciences CAR-T Drugs Product and Services
7.8.4 Precision Biosciences CAR-T Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Precision Biosciences Recent Developments/Updates
7.8.6 Precision Biosciences Competitive Strengths & Weaknesses
7.9 CRISPR Therapeutics
7.9.1 CRISPR Therapeutics Details
7.9.2 CRISPR Therapeutics Major Business
7.9.3 CRISPR Therapeutics CAR-T Drugs Product and Services
7.9.4 CRISPR Therapeutics CAR-T Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 CRISPR Therapeutics Recent Developments/Updates
7.9.6 CRISPR Therapeutics Competitive Strengths & Weaknesses
7.10 Autolus Therapeutics
7.10.1 Autolus Therapeutics Details
7.10.2 Autolus Therapeutics Major Business
7.10.3 Autolus Therapeutics CAR-T Drugs Product and Services
7.10.4 Autolus Therapeutics CAR-T Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Autolus Therapeutics Recent Developments/Updates
7.10.6 Autolus Therapeutics Competitive Strengths & Weaknesses
7.11 Adaptimmune Therapeutics
7.11.1 Adaptimmune Therapeutics Details
7.11.2 Adaptimmune Therapeutics Major Business
7.11.3 Adaptimmune Therapeutics CAR-T Drugs Product and Services
7.11.4 Adaptimmune Therapeutics CAR-T Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Adaptimmune Therapeutics Recent Developments/Updates
7.11.6 Adaptimmune Therapeutics Competitive Strengths & Weaknesses
7.12 Atara Biotherapeutics
7.12.1 Atara Biotherapeutics Details
7.12.2 Atara Biotherapeutics Major Business
7.12.3 Atara Biotherapeutics CAR-T Drugs Product and Services
7.12.4 Atara Biotherapeutics CAR-T Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Atara Biotherapeutics Recent Developments/Updates
7.12.6 Atara Biotherapeutics Competitive Strengths & Weaknesses
7.13 Tmunity Therapeutics
7.13.1 Tmunity Therapeutics Details
7.13.2 Tmunity Therapeutics Major Business
7.13.3 Tmunity Therapeutics CAR-T Drugs Product and Services
7.13.4 Tmunity Therapeutics CAR-T Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Tmunity Therapeutics Recent Developments/Updates
7.13.6 Tmunity Therapeutics Competitive Strengths & Weaknesses
7.14 Iovance Biotherapeutics
7.14.1 Iovance Biotherapeutics Details
7.14.2 Iovance Biotherapeutics Major Business
7.14.3 Iovance Biotherapeutics CAR-T Drugs Product and Services
7.14.4 Iovance Biotherapeutics CAR-T Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Iovance Biotherapeutics Recent Developments/Updates
7.14.6 Iovance Biotherapeutics Competitive Strengths & Weaknesses
7.15 Celyad Oncology
7.15.1 Celyad Oncology Details
7.15.2 Celyad Oncology Major Business
7.15.3 Celyad Oncology CAR-T Drugs Product and Services
7.15.4 Celyad Oncology CAR-T Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Celyad Oncology Recent Developments/Updates
7.15.6 Celyad Oncology Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 CAR-T Drugs Industry Chain
8.2 CAR-T Drugs Upstream Analysis
8.2.1 CAR-T Drugs Core Raw Materials
8.2.2 Main Manufacturers of CAR-T Drugs Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 CAR-T Drugs Production Mode
8.6 CAR-T Drugs Procurement Model
8.7 CAR-T Drugs Industry Sales Model and Sales Channels
8.7.1 CAR-T Drugs Sales Model
8.7.2 CAR-T Drugs Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World CAR-T Drugs Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World CAR-T Drugs Production Value by Region (2018-2023) & (USD Million)
Table 3. World CAR-T Drugs Production Value by Region (2024-2029) & (USD Million)
Table 4. World CAR-T Drugs Production Value Market Share by Region (2018-2023)
Table 5. World CAR-T Drugs Production Value Market Share by Region (2024-2029)
Table 6. World CAR-T Drugs Production by Region (2018-2023) & (K Units)
Table 7. World CAR-T Drugs Production by Region (2024-2029) & (K Units)
Table 8. World CAR-T Drugs Production Market Share by Region (2018-2023)
Table 9. World CAR-T Drugs Production Market Share by Region (2024-2029)
Table 10. World CAR-T Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World CAR-T Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 12. CAR-T Drugs Major Market Trends
Table 13. World CAR-T Drugs Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World CAR-T Drugs Consumption by Region (2018-2023) & (K Units)
Table 15. World CAR-T Drugs Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World CAR-T Drugs Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key CAR-T Drugs Producers in 2022
Table 18. World CAR-T Drugs Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key CAR-T Drugs Producers in 2022
Table 20. World CAR-T Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global CAR-T Drugs Company Evaluation Quadrant
Table 22. World CAR-T Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and CAR-T Drugs Production Site of Key Manufacturer
Table 24. CAR-T Drugs Market: Company Product Type Footprint
Table 25. CAR-T Drugs Market: Company Product Application Footprint
Table 26. CAR-T Drugs Competitive Factors
Table 27. CAR-T Drugs New Entrant and Capacity Expansion Plans
Table 28. CAR-T Drugs Mergers & Acquisitions Activity
Table 29. United States VS China CAR-T Drugs Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China CAR-T Drugs Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China CAR-T Drugs Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based CAR-T Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers CAR-T Drugs Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers CAR-T Drugs Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers CAR-T Drugs Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers CAR-T Drugs Production Market Share (2018-2023)
Table 37. China Based CAR-T Drugs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers CAR-T Drugs Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers CAR-T Drugs Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers CAR-T Drugs Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers CAR-T Drugs Production Market Share (2018-2023)
Table 42. Rest of World Based CAR-T Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers CAR-T Drugs Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers CAR-T Drugs Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers CAR-T Drugs Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers CAR-T Drugs Production Market Share (2018-2023)
Table 47. World CAR-T Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World CAR-T Drugs Production by Type (2018-2023) & (K Units)
Table 49. World CAR-T Drugs Production by Type (2024-2029) & (K Units)
Table 50. World CAR-T Drugs Production Value by Type (2018-2023) & (USD Million)
Table 51. World CAR-T Drugs Production Value by Type (2024-2029) & (USD Million)
Table 52. World CAR-T Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World CAR-T Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World CAR-T Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World CAR-T Drugs Production by Application (2018-2023) & (K Units)
Table 56. World CAR-T Drugs Production by Application (2024-2029) & (K Units)
Table 57. World CAR-T Drugs Production Value by Application (2018-2023) & (USD Million)
Table 58. World CAR-T Drugs Production Value by Application (2024-2029) & (USD Million)
Table 59. World CAR-T Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World CAR-T Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Novartis Basic Information, Manufacturing Base and Competitors
Table 62. Novartis Major Business
Table 63. Novartis CAR-T Drugs Product and Services
Table 64. Novartis CAR-T Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Novartis Recent Developments/Updates
Table 66. Novartis Competitive Strengths & Weaknesses
Table 67. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 68. Gilead Sciences Major Business
Table 69. Gilead Sciences CAR-T Drugs Product and Services
Table 70. Gilead Sciences CAR-T Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Gilead Sciences Recent Developments/Updates
Table 72. Gilead Sciences Competitive Strengths & Weaknesses
Table 73. WuXi Biologics Basic Information, Manufacturing Base and Competitors
Table 74. WuXi Biologics Major Business
Table 75. WuXi Biologics CAR-T Drugs Product and Services
Table 76. WuXi Biologics CAR-T Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. WuXi Biologics Recent Developments/Updates
Table 78. WuXi Biologics Competitive Strengths & Weaknesses
Table 79. Sanofi Basic Information, Manufacturing Base and Competitors
Table 80. Sanofi Major Business
Table 81. Sanofi CAR-T Drugs Product and Services
Table 82. Sanofi CAR-T Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Sanofi Recent Developments/Updates
Table 84. Sanofi Competitive Strengths & Weaknesses
Table 85. Juno Therapeutics Basic Information, Manufacturing Base and Competitors
Table 86. Juno Therapeutics Major Business
Table 87. Juno Therapeutics CAR-T Drugs Product and Services
Table 88. Juno Therapeutics CAR-T Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Juno Therapeutics Recent Developments/Updates
Table 90. Juno Therapeutics Competitive Strengths & Weaknesses
Table 91. Bluebird Bio Basic Information, Manufacturing Base and Competitors
Table 92. Bluebird Bio Major Business
Table 93. Bluebird Bio CAR-T Drugs Product and Services
Table 94. Bluebird Bio CAR-T Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Bluebird Bio Recent Developments/Updates
Table 96. Bluebird Bio Competitive Strengths & Weaknesses
Table 97. Cellectis Basic Information, Manufacturing Base and Competitors
Table 98. Cellectis Major Business
Table 99. Cellectis CAR-T Drugs Product and Services
Table 100. Cellectis CAR-T Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Cellectis Recent Developments/Updates
Table 102. Cellectis Competitive Strengths & Weaknesses
Table 103. Precision Biosciences Basic Information, Manufacturing Base and Competitors
Table 104. Precision Biosciences Major Business
Table 105. Precision Biosciences CAR-T Drugs Product and Services
Table 106. Precision Biosciences CAR-T Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Precision Biosciences Recent Developments/Updates
Table 108. Precision Biosciences Competitive Strengths & Weaknesses
Table 109. CRISPR Therapeutics Basic Information, Manufacturing Base and Competitors
Table 110. CRISPR Therapeutics Major Business
Table 111. CRISPR Therapeutics CAR-T Drugs Product and Services
Table 112. CRISPR Therapeutics CAR-T Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. CRISPR Therapeutics Recent Developments/Updates
Table 114. CRISPR Therapeutics Competitive Strengths & Weaknesses
Table 115. Autolus Therapeutics Basic Information, Manufacturing Base and Competitors
Table 116. Autolus Therapeutics Major Business
Table 117. Autolus Therapeutics CAR-T Drugs Product and Services
Table 118. Autolus Therapeutics CAR-T Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Autolus Therapeutics Recent Developments/Updates
Table 120. Autolus Therapeutics Competitive Strengths & Weaknesses
Table 121. Adaptimmune Therapeutics Basic Information, Manufacturing Base and Competitors
Table 122. Adaptimmune Therapeutics Major Business
Table 123. Adaptimmune Therapeutics CAR-T Drugs Product and Services
Table 124. Adaptimmune Therapeutics CAR-T Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Adaptimmune Therapeutics Recent Developments/Updates
Table 126. Adaptimmune Therapeutics Competitive Strengths & Weaknesses
Table 127. Atara Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table 128. Atara Biotherapeutics Major Business
Table 129. Atara Biotherapeutics CAR-T Drugs Product and Services
Table 130. Atara Biotherapeutics CAR-T Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Atara Biotherapeutics Recent Developments/Updates
Table 132. Atara Biotherapeutics Competitive Strengths & Weaknesses
Table 133. Tmunity Therapeutics Basic Information, Manufacturing Base and Competitors
Table 134. Tmunity Therapeutics Major Business
Table 135. Tmunity Therapeutics CAR-T Drugs Product and Services
Table 136. Tmunity Therapeutics CAR-T Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Tmunity Therapeutics Recent Developments/Updates
Table 138. Tmunity Therapeutics Competitive Strengths & Weaknesses
Table 139. Iovance Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table 140. Iovance Biotherapeutics Major Business
Table 141. Iovance Biotherapeutics CAR-T Drugs Product and Services
Table 142. Iovance Biotherapeutics CAR-T Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Iovance Biotherapeutics Recent Developments/Updates
Table 144. Celyad Oncology Basic Information, Manufacturing Base and Competitors
Table 145. Celyad Oncology Major Business
Table 146. Celyad Oncology CAR-T Drugs Product and Services
Table 147. Celyad Oncology CAR-T Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 148. Global Key Players of CAR-T Drugs Upstream (Raw Materials)
Table 149. CAR-T Drugs Typical Customers
Table 150. CAR-T Drugs Typical Distributors
LIST OF FIGURE
Figure 1. CAR-T Drugs Picture
Figure 2. World CAR-T Drugs Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World CAR-T Drugs Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World CAR-T Drugs Production (2018-2029) & (K Units)
Figure 5. World CAR-T Drugs Average Price (2018-2029) & (US$/Unit)
Figure 6. World CAR-T Drugs Production Value Market Share by Region (2018-2029)
Figure 7. World CAR-T Drugs Production Market Share by Region (2018-2029)
Figure 8. North America CAR-T Drugs Production (2018-2029) & (K Units)
Figure 9. Europe CAR-T Drugs Production (2018-2029) & (K Units)
Figure 10. China CAR-T Drugs Production (2018-2029) & (K Units)
Figure 11. Japan CAR-T Drugs Production (2018-2029) & (K Units)
Figure 12. CAR-T Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World CAR-T Drugs Consumption (2018-2029) & (K Units)
Figure 15. World CAR-T Drugs Consumption Market Share by Region (2018-2029)
Figure 16. United States CAR-T Drugs Consumption (2018-2029) & (K Units)
Figure 17. China CAR-T Drugs Consumption (2018-2029) & (K Units)
Figure 18. Europe CAR-T Drugs Consumption (2018-2029) & (K Units)
Figure 19. Japan CAR-T Drugs Consumption (2018-2029) & (K Units)
Figure 20. South Korea CAR-T Drugs Consumption (2018-2029) & (K Units)
Figure 21. ASEAN CAR-T Drugs Consumption (2018-2029) & (K Units)
Figure 22. India CAR-T Drugs Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of CAR-T Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for CAR-T Drugs Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for CAR-T Drugs Markets in 2022
Figure 26. United States VS China: CAR-T Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: CAR-T Drugs Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: CAR-T Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers CAR-T Drugs Production Market Share 2022
Figure 30. China Based Manufacturers CAR-T Drugs Production Market Share 2022
Figure 31. Rest of World Based Manufacturers CAR-T Drugs Production Market Share 2022
Figure 32. World CAR-T Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World CAR-T Drugs Production Value Market Share by Type in 2022
Figure 34. CD19 CAR-T
Figure 35. BCMACAR-T
Figure 36. Others
Figure 37. World CAR-T Drugs Production Market Share by Type (2018-2029)
Figure 38. World CAR-T Drugs Production Value Market Share by Type (2018-2029)
Figure 39. World CAR-T Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World CAR-T Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World CAR-T Drugs Production Value Market Share by Application in 2022
Figure 42. Hematoma
Figure 43. Solid Tumors
Figure 44. Others
Figure 45. World CAR-T Drugs Production Market Share by Application (2018-2029)
Figure 46. World CAR-T Drugs Production Value Market Share by Application (2018-2029)
Figure 47. World CAR-T Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. CAR-T Drugs Industry Chain
Figure 49. CAR-T Drugs Procurement Model
Figure 50. CAR-T Drugs Sales Model
Figure 51. CAR-T Drugs Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
Table 1. World CAR-T Drugs Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World CAR-T Drugs Production Value by Region (2018-2023) & (USD Million)
Table 3. World CAR-T Drugs Production Value by Region (2024-2029) & (USD Million)
Table 4. World CAR-T Drugs Production Value Market Share by Region (2018-2023)
Table 5. World CAR-T Drugs Production Value Market Share by Region (2024-2029)
Table 6. World CAR-T Drugs Production by Region (2018-2023) & (K Units)
Table 7. World CAR-T Drugs Production by Region (2024-2029) & (K Units)
Table 8. World CAR-T Drugs Production Market Share by Region (2018-2023)
Table 9. World CAR-T Drugs Production Market Share by Region (2024-2029)
Table 10. World CAR-T Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World CAR-T Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 12. CAR-T Drugs Major Market Trends
Table 13. World CAR-T Drugs Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World CAR-T Drugs Consumption by Region (2018-2023) & (K Units)
Table 15. World CAR-T Drugs Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World CAR-T Drugs Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key CAR-T Drugs Producers in 2022
Table 18. World CAR-T Drugs Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key CAR-T Drugs Producers in 2022
Table 20. World CAR-T Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global CAR-T Drugs Company Evaluation Quadrant
Table 22. World CAR-T Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and CAR-T Drugs Production Site of Key Manufacturer
Table 24. CAR-T Drugs Market: Company Product Type Footprint
Table 25. CAR-T Drugs Market: Company Product Application Footprint
Table 26. CAR-T Drugs Competitive Factors
Table 27. CAR-T Drugs New Entrant and Capacity Expansion Plans
Table 28. CAR-T Drugs Mergers & Acquisitions Activity
Table 29. United States VS China CAR-T Drugs Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China CAR-T Drugs Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China CAR-T Drugs Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based CAR-T Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers CAR-T Drugs Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers CAR-T Drugs Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers CAR-T Drugs Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers CAR-T Drugs Production Market Share (2018-2023)
Table 37. China Based CAR-T Drugs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers CAR-T Drugs Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers CAR-T Drugs Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers CAR-T Drugs Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers CAR-T Drugs Production Market Share (2018-2023)
Table 42. Rest of World Based CAR-T Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers CAR-T Drugs Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers CAR-T Drugs Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers CAR-T Drugs Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers CAR-T Drugs Production Market Share (2018-2023)
Table 47. World CAR-T Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World CAR-T Drugs Production by Type (2018-2023) & (K Units)
Table 49. World CAR-T Drugs Production by Type (2024-2029) & (K Units)
Table 50. World CAR-T Drugs Production Value by Type (2018-2023) & (USD Million)
Table 51. World CAR-T Drugs Production Value by Type (2024-2029) & (USD Million)
Table 52. World CAR-T Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World CAR-T Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World CAR-T Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World CAR-T Drugs Production by Application (2018-2023) & (K Units)
Table 56. World CAR-T Drugs Production by Application (2024-2029) & (K Units)
Table 57. World CAR-T Drugs Production Value by Application (2018-2023) & (USD Million)
Table 58. World CAR-T Drugs Production Value by Application (2024-2029) & (USD Million)
Table 59. World CAR-T Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World CAR-T Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Novartis Basic Information, Manufacturing Base and Competitors
Table 62. Novartis Major Business
Table 63. Novartis CAR-T Drugs Product and Services
Table 64. Novartis CAR-T Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Novartis Recent Developments/Updates
Table 66. Novartis Competitive Strengths & Weaknesses
Table 67. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 68. Gilead Sciences Major Business
Table 69. Gilead Sciences CAR-T Drugs Product and Services
Table 70. Gilead Sciences CAR-T Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Gilead Sciences Recent Developments/Updates
Table 72. Gilead Sciences Competitive Strengths & Weaknesses
Table 73. WuXi Biologics Basic Information, Manufacturing Base and Competitors
Table 74. WuXi Biologics Major Business
Table 75. WuXi Biologics CAR-T Drugs Product and Services
Table 76. WuXi Biologics CAR-T Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. WuXi Biologics Recent Developments/Updates
Table 78. WuXi Biologics Competitive Strengths & Weaknesses
Table 79. Sanofi Basic Information, Manufacturing Base and Competitors
Table 80. Sanofi Major Business
Table 81. Sanofi CAR-T Drugs Product and Services
Table 82. Sanofi CAR-T Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Sanofi Recent Developments/Updates
Table 84. Sanofi Competitive Strengths & Weaknesses
Table 85. Juno Therapeutics Basic Information, Manufacturing Base and Competitors
Table 86. Juno Therapeutics Major Business
Table 87. Juno Therapeutics CAR-T Drugs Product and Services
Table 88. Juno Therapeutics CAR-T Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Juno Therapeutics Recent Developments/Updates
Table 90. Juno Therapeutics Competitive Strengths & Weaknesses
Table 91. Bluebird Bio Basic Information, Manufacturing Base and Competitors
Table 92. Bluebird Bio Major Business
Table 93. Bluebird Bio CAR-T Drugs Product and Services
Table 94. Bluebird Bio CAR-T Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Bluebird Bio Recent Developments/Updates
Table 96. Bluebird Bio Competitive Strengths & Weaknesses
Table 97. Cellectis Basic Information, Manufacturing Base and Competitors
Table 98. Cellectis Major Business
Table 99. Cellectis CAR-T Drugs Product and Services
Table 100. Cellectis CAR-T Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Cellectis Recent Developments/Updates
Table 102. Cellectis Competitive Strengths & Weaknesses
Table 103. Precision Biosciences Basic Information, Manufacturing Base and Competitors
Table 104. Precision Biosciences Major Business
Table 105. Precision Biosciences CAR-T Drugs Product and Services
Table 106. Precision Biosciences CAR-T Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Precision Biosciences Recent Developments/Updates
Table 108. Precision Biosciences Competitive Strengths & Weaknesses
Table 109. CRISPR Therapeutics Basic Information, Manufacturing Base and Competitors
Table 110. CRISPR Therapeutics Major Business
Table 111. CRISPR Therapeutics CAR-T Drugs Product and Services
Table 112. CRISPR Therapeutics CAR-T Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. CRISPR Therapeutics Recent Developments/Updates
Table 114. CRISPR Therapeutics Competitive Strengths & Weaknesses
Table 115. Autolus Therapeutics Basic Information, Manufacturing Base and Competitors
Table 116. Autolus Therapeutics Major Business
Table 117. Autolus Therapeutics CAR-T Drugs Product and Services
Table 118. Autolus Therapeutics CAR-T Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Autolus Therapeutics Recent Developments/Updates
Table 120. Autolus Therapeutics Competitive Strengths & Weaknesses
Table 121. Adaptimmune Therapeutics Basic Information, Manufacturing Base and Competitors
Table 122. Adaptimmune Therapeutics Major Business
Table 123. Adaptimmune Therapeutics CAR-T Drugs Product and Services
Table 124. Adaptimmune Therapeutics CAR-T Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Adaptimmune Therapeutics Recent Developments/Updates
Table 126. Adaptimmune Therapeutics Competitive Strengths & Weaknesses
Table 127. Atara Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table 128. Atara Biotherapeutics Major Business
Table 129. Atara Biotherapeutics CAR-T Drugs Product and Services
Table 130. Atara Biotherapeutics CAR-T Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Atara Biotherapeutics Recent Developments/Updates
Table 132. Atara Biotherapeutics Competitive Strengths & Weaknesses
Table 133. Tmunity Therapeutics Basic Information, Manufacturing Base and Competitors
Table 134. Tmunity Therapeutics Major Business
Table 135. Tmunity Therapeutics CAR-T Drugs Product and Services
Table 136. Tmunity Therapeutics CAR-T Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Tmunity Therapeutics Recent Developments/Updates
Table 138. Tmunity Therapeutics Competitive Strengths & Weaknesses
Table 139. Iovance Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table 140. Iovance Biotherapeutics Major Business
Table 141. Iovance Biotherapeutics CAR-T Drugs Product and Services
Table 142. Iovance Biotherapeutics CAR-T Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Iovance Biotherapeutics Recent Developments/Updates
Table 144. Celyad Oncology Basic Information, Manufacturing Base and Competitors
Table 145. Celyad Oncology Major Business
Table 146. Celyad Oncology CAR-T Drugs Product and Services
Table 147. Celyad Oncology CAR-T Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 148. Global Key Players of CAR-T Drugs Upstream (Raw Materials)
Table 149. CAR-T Drugs Typical Customers
Table 150. CAR-T Drugs Typical Distributors
LIST OF FIGURE
Figure 1. CAR-T Drugs Picture
Figure 2. World CAR-T Drugs Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World CAR-T Drugs Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World CAR-T Drugs Production (2018-2029) & (K Units)
Figure 5. World CAR-T Drugs Average Price (2018-2029) & (US$/Unit)
Figure 6. World CAR-T Drugs Production Value Market Share by Region (2018-2029)
Figure 7. World CAR-T Drugs Production Market Share by Region (2018-2029)
Figure 8. North America CAR-T Drugs Production (2018-2029) & (K Units)
Figure 9. Europe CAR-T Drugs Production (2018-2029) & (K Units)
Figure 10. China CAR-T Drugs Production (2018-2029) & (K Units)
Figure 11. Japan CAR-T Drugs Production (2018-2029) & (K Units)
Figure 12. CAR-T Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World CAR-T Drugs Consumption (2018-2029) & (K Units)
Figure 15. World CAR-T Drugs Consumption Market Share by Region (2018-2029)
Figure 16. United States CAR-T Drugs Consumption (2018-2029) & (K Units)
Figure 17. China CAR-T Drugs Consumption (2018-2029) & (K Units)
Figure 18. Europe CAR-T Drugs Consumption (2018-2029) & (K Units)
Figure 19. Japan CAR-T Drugs Consumption (2018-2029) & (K Units)
Figure 20. South Korea CAR-T Drugs Consumption (2018-2029) & (K Units)
Figure 21. ASEAN CAR-T Drugs Consumption (2018-2029) & (K Units)
Figure 22. India CAR-T Drugs Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of CAR-T Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for CAR-T Drugs Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for CAR-T Drugs Markets in 2022
Figure 26. United States VS China: CAR-T Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: CAR-T Drugs Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: CAR-T Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers CAR-T Drugs Production Market Share 2022
Figure 30. China Based Manufacturers CAR-T Drugs Production Market Share 2022
Figure 31. Rest of World Based Manufacturers CAR-T Drugs Production Market Share 2022
Figure 32. World CAR-T Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World CAR-T Drugs Production Value Market Share by Type in 2022
Figure 34. CD19 CAR-T
Figure 35. BCMACAR-T
Figure 36. Others
Figure 37. World CAR-T Drugs Production Market Share by Type (2018-2029)
Figure 38. World CAR-T Drugs Production Value Market Share by Type (2018-2029)
Figure 39. World CAR-T Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World CAR-T Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World CAR-T Drugs Production Value Market Share by Application in 2022
Figure 42. Hematoma
Figure 43. Solid Tumors
Figure 44. Others
Figure 45. World CAR-T Drugs Production Market Share by Application (2018-2029)
Figure 46. World CAR-T Drugs Production Value Market Share by Application (2018-2029)
Figure 47. World CAR-T Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. CAR-T Drugs Industry Chain
Figure 49. CAR-T Drugs Procurement Model
Figure 50. CAR-T Drugs Sales Model
Figure 51. CAR-T Drugs Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
